Sunshine Biopharma (SBFM) Profit After Tax: 2010-2025
Historic Profit After Tax for Sunshine Biopharma (SBFM) over the last 14 years, with Sep 2025 value amounting to -$883,820.
- Sunshine Biopharma's Profit After Tax rose 26.21% to -$883,820 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 million, marking a year-over-year decrease of 41.81%. This contributed to the annual value of -$5.1 million for FY2024, which is 13.94% down from last year.
- Sunshine Biopharma's Profit After Tax amounted to -$883,820 in Q3 2025, which was up 50.09% from -$1.8 million recorded in Q2 2025.
- Sunshine Biopharma's Profit After Tax's 5-year high stood at $667,116 during Q4 2021, with a 5-year trough of -$23.5 million in Q4 2022.
- Moreover, its 3-year median value for Profit After Tax was -$1.2 million (2024), whereas its average is -$1.2 million.
- Examining YoY changes over the last 5 years, Sunshine Biopharma's Profit After Tax showed a top increase of 161.55% in 2021 and a maximum decrease of 6,461.84% in 2021.
- Over the past 5 years, Sunshine Biopharma's Profit After Tax (Quarterly) stood at $667,116 in 2021, then slumped by 3,624.47% to -$23.5 million in 2022, then skyrocketed by 94.68% to -$1.3 million in 2023, then slumped by 72.65% to -$2.2 million in 2024, then increased by 26.21% to -$883,820 in 2025.
- Its last three reported values are -$883,820 in Q3 2025, -$1.8 million for Q2 2025, and -$1.2 million during Q1 2025.